- Home
- SIGA vs GUG Comparison
SIGA vs GUG Comparison
Compare SIGA & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- GUG
- Stock Information
- Founded
- SIGA 1995
- GUG 2021
- Country
- SIGA United States
- GUG United States
- Employees
- SIGA N/A
- GUG N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- GUG Trusts Except Educational Religious and Charitable
- Sector
- SIGA Health Care
- GUG Finance
- Exchange
- SIGA Nasdaq
- GUG Nasdaq
- Market Cap
- SIGA 515.1M
- GUG 470.0M
- IPO Year
- SIGA 1997
- GUG N/A
- Fundamental
- Price
- SIGA $6.46
- GUG $15.26
- Analyst Decision
- SIGA
- GUG
- Analyst Count
- SIGA 0
- GUG 0
- Target Price
- SIGA N/A
- GUG N/A
- AVG Volume (30 Days)
- SIGA 328.2K
- GUG 108.9K
- Earning Date
- SIGA 08-05-2025
- GUG 01-01-0001
- Dividend Yield
- SIGA 9.22%
- GUG 9.67%
- EPS Growth
- SIGA N/A
- GUG N/A
- EPS
- SIGA 0.67
- GUG N/A
- Revenue
- SIGA $120,330,310.00
- GUG N/A
- Revenue This Year
- SIGA N/A
- GUG N/A
- Revenue Next Year
- SIGA $95.31
- GUG N/A
- P/E Ratio
- SIGA $9.70
- GUG N/A
- Revenue Growth
- SIGA N/A
- GUG N/A
- 52 Week Low
- SIGA $4.95
- GUG $12.71
- 52 Week High
- SIGA $12.83
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- SIGA 42.33
- GUG 41.65
- Support Level
- SIGA $6.97
- GUG $15.26
- Resistance Level
- SIGA $7.32
- GUG $15.49
- Average True Range (ATR)
- SIGA 0.21
- GUG 0.22
- MACD
- SIGA -0.07
- GUG -0.01
- Stochastic Oscillator
- SIGA 7.53
- GUG 16.89
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.